Unusual clinical presentations of brucellosis.
The purpose of this paper is to draw attention to atypical presentations of brucellosis. A prospective study identified 240 consecutive patients with brucellosis admitted to our department between December 1999 and July 2002. From these cases we present 11 patients with unusual clinical presentations. Neurobrucellosis, peritonitis, pericarditis, pancytopenia, and uveitis were diagnosed in 2 patients each and 1 presented with epididymo-orchitis.
Hatipoglu
Cigdem Ataman
CA
Department of Infectious Diseases and Clinical Microbiology, Ankara Training and Research Hospital, Ankara 06340, Turkey. cigdemhatip@yahoo.com
Yetkin
Arzu
A
Ertem
Gunay Tuncer
GT
Tulek
Necla
N
D000328:Adult; D017677:Age Distribution; D000900:Anti-Bacterial Agents; D017347:Brucella melitensis / Q000302:isolation & purification*; D002006:Brucellosis / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009920:Orchitis / Q000188:drug therapy / Q000382:microbiology; D010198:Pancytopenia / Q000188:drug therapy / Q000382:microbiology; D010493:Pericarditis / Q000188:drug therapy / Q000382:microbiology; D010538:Peritonitis / Q000188:drug therapy / Q000382:microbiology; D011379:Prognosis; D011446:Prospective Studies; D018570:Risk Assessment; D012720:Severity of Illness Index; D017678:Sex Distribution; D016896:Treatment Outcome; D014421:Turkey / Q000453:epidemiology; D014605:Uveitis / Q000188:drug therapy / Q000382:microbiology
D000900:Anti-Bacterial Agents